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Intestinal colonization by enteropathogenic and enterohemorrhagic Escherichia coli requires the locus of
enterocyte effacement-encoded type III secretion system. We report that NleC and NleD are translocated into
host cells via this system. Deletion mutants induced attaching and effacing lesions in vitro, while infection of
calves or lambs showed that neither gene was required for colonization.
Attaching and effacing strains of Escherichia coli (AEEC)
comprise a group of gastrointestinal pathogens of humans and
animals that induce distinctive attaching and effacing (A/E)
lesions within the host intestinal mucosa (28). A/E lesions are
characterized by intimate attachment of the bacteria to the
host cell surface, the localized destruction of intestinal mi-
crovilli, and the rearrangement of host cytoskeletal proteins
beneath the adherent bacteria (19). A/E lesion formation is
mediated by the products of the locus of enterocyte effacement
(LEE) pathogenicity island (PAI) (24). The LEE of entero-
pathogenic E. coli (EPEC) contains 41 open reading frames
(11) of which approximately half encode a type III secretion
system (TTSS), which directs the secretion of several LEE-en-
coded translocator (EspA, EspB, and EspD) and effector (EspG,
EspH, Map, Tir, EspZ, and EspF) proteins. However, only Tir
plays a direct role in A/E lesion formation (12, 13). The LEE PAI
is well conserved among AEEC strains, including the closely re-
lated human pathogen enterohemorrhagic E. coli (EHEC) (30)
and the animal pathogens rabbit-specific enteropathogenic E. coli
(35) and Citrobacter rodentium (7).
Recently, several novel effector proteins that are not en-
coded within the LEE but are translocated into host cells by
the LEE-encoded TTSS were described. Cycle inhibiting factor
(designated Cif), although not required for A/E lesion forma-
tion, induces host cell cycle arrest and reorganization of the
actin cytoskeleton (21). EspI/NleA (for non-LEE encoded)
(Z6024) (15, 25) is also not required for A/E lesion formation
but is essential for full virulence in the C. rodentium mouse
model of infection and was found to be more frequently as-
sociated with EHEC strains isolated from symptomatic than
from asymptomatic patients (26). EspJ (5) and TccP/EspFU (3,
14) are carried on prophage CP933U. In the murine model
of infection, an espJ deletion mutant of C. rodentium showed
altered colonization and clearance dynamics, although the pro-
tein was not required for A/E lesion formation (5). In contrast,
TccP/EspFU is essential for A/E lesion formation by EHEC
O157:H7 (3, 14) and disruption of the tight junctions (38). In
EHEC O157:H7-infected cells, TccP functions as a linker be-
tween Tir and N-WASP and compensates functionally for the
absence of the host adapter protein, Nck, which in EPEC-
infected cells is recruited to the pedestal upon tyrosine phos-
phorylation of Tir (1, 2). EspG2, which is encoded on the EspC
PAI, shares similarity with EspG (10) and was recently shown
to interact with tubulin and trigger the dissociation of micro-
tubules beneath adherent bacteria in a manner similar to that
of EspG (23, 32).
Several other secreted proteins, encoded at different positions
on the chromosome, have been identified through proteomic
analysis of the secretome of C. rodentium and shown to be se-
creted by the LEE-encoded TTSS, although it is still unclear if
these proteins constitute novel translocated effectors (8). These
include NleB (Z4328), NleC (Z0986), NleD (Z0990), NleE
(Z4329), and NleF (Z6020). Recently, the gene encoding NleD
was identified during a signature-tagged mutagenesis screen as
essential for full colonization of the bovine gut by EHEC
O157:H7 strain EDL933 (9). In this study, we investigated
whether NleD and another putative effector present in the same
O-island, NleC, were translocated into host cells by the LEE-
encoded TTSS and the contribution of nleC and nleD to virulence
in several in vitro and in vivo models of infection.
Sequence analysis of the putative type III-secreted effectors,
NleC and NleD. The respective EHEC O157:H7 homologs of
NleC and NleD proteins, Z0986 and Z0990, show 95% and
* Corresponding author. Mailing address: CMMI, Flowers Building,
Imperial College London, London SW7 2AZ, United Kingdom. Phone:
44 (0) 20 7594 5253. Fax: 44 (0) 20 7594 3069. E-mail: g.frankel
@imperial.ac.uk.
8411
84% amino acid similarity with their C. rodentium counterparts
(http://www.sanger.ac.uk/Projects/C_rodentium) and are en-
coded within prophage CP-933K in EHEC O157:H7 EDL933,
which corresponds to O-island 36 (Fig. 1A). Z0986/NleC is
predicted to be 330 amino acids in length with a molecular
mass of 37 kDa; Z0990/NleD is predicted to be 232 amino
acids with a molecular mass of 26 kDa. Sequences homologous
to Z0986/NleC and Z0990/NleD are also present in the unfin-
ished genome sequence of EPEC strain E2348/69 (http://www
.sanger.ac.uk/projects/Escherichia_Shigella), sharing 100% and 99%
similarity, respectively, with their counterparts in EHEC O157:
H7. Whereas Z0986/NleC shows no similarity to proteins of
non-AEEC pathogens, Z0990/NleD exhibits 38% similarity
with the type III effector HopPtoH from Pseudomonas syringae
(31), 36% similarity with protein XCC3258 from Xanthomonas
campestris, and 45% and 42% similarity with proteins RSc3290
and RS03907, respectively, from Ralstonia solanacearum strain
GMI1000 (Fig. 1B). Although the function of these proteins is
unknown, the shared similarity extends to a conserved zinc
binding motif, which suggests that these proteins could have a
metallopeptidase activity.
Secretion and translocation of NleC and NleD into host cells.
Recently, a system to study protein secretion and translocation
was developed that utilizes translational fusions to TEM-1
-lactamase (4). TEM-1 -lactamase lacks a leader peptide
sequence for export and can only be secreted if fused to a
secreted protein. Likewise, TEM-1 translocation into host cells
can only occur if TEM-1 is fused to a translocated protein. The
presence of TEM-1 in infected eukaryotic cells can be mea-
sured directly by the addition of the fluorescent substrate
CCF2-AM. Eukaryotic cells containing TEM-1 cleave CCF2-
AM and appear blue under UV illumination, while cells lack-
ing TEM-1 do not cleave CCF2-AM and appear green. To
determine if Z0986/NleC and Z0990/NleD were translocated
into host cells by the LEE-encoded TTSS, translational fusions
with TEM-1 were constructed in plasmid pCX340 (Table 1). A
776-bp fragment containing the gene nleD was amplified by
PCR using primers Z0990NdeIf and Z0990EcoRIr (Table 2)
using genomic DNA from EPEC E2348/69 as a template. The
PCR product was digested by NdeI and EcoRI and ligated into
pCX340, generating plasmid pICC309 encoding an NleD–
TEM-1 fusion. Plasmid pICC308 encoding an NleC–TEM-1
fusion was obtained in the same way after NdeI/EcoRI diges-
tion and ligation of a 1,110-bp PCR product amplified with
primers Z0986Nde1f and Z0986EcoRr (Table 2). Plasmids
pICC308 and pICC309 were introduced into EPEC E2348/69
and an escN mutant of EPEC E2348/69, ICC192; the recom-
binant strains, grown in Dulbecco’s modified Eagle medium
(DMEM), were analyzed for protein secretion. Western blot
analysis with antibodies to TEM-1 showed that the NleC–
TEM-1 and NleD–TEM-1 fusion proteins were secreted into
FIG. 1. The deletion of nleC (A) and nleD (not shown) was con-
firmed by Southern blot analysis. NleD and NleC are encoded at the 5
end of prophage CP-933K inserted in the bio operon located at
17.3 min in the K-12 chromosome. (B) The locus encoding NleD and
NleC also encodes two other putative type III-secreted effectors, NleB
and NleH. (C) Alignments of the zinc binding motifs (indicated by an
asterisk) located in the C-terminal domains of NleD with type III-
secreted effector proteins of plant pathogens.
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Characteristic(s) Referenceor source
Strains
EPEC E2348/69 Wild-type EPEC O127:H6 20
EHEC 85-170 Spontaneous stx1 and stx2 minus EHEC O157:H7 36
85-170 nalr Spontaneous Nalr derivative of 85-170 33
ICC192 E2348/69 escN::Kan 14
ICC195 85-170 nleC::Kan (Nalr Kanr) This study
ICC196 85-170 nleD::Kan (Nalr Kanr) This study
ICC193 E2348/69 nleC::Kan This study
ICC194 E2348/69 nleD::Kan This study
Plasmids
pCX340 Cloning vector used to construct TEM-1 -lactamase fusions; Tetr 4
pKD4 oriR101 blaM; Kanr cassette flanked by FRT sites 6
pKD46 oriR101 repA101(ts) araBp-gam-bet-exo blaM 6
pICC308 Derivative of pCX340 encoding an NleC–TEM-1 fusion This study
pICC309 Derivative of pCX340 encoding an NleD–TEM-1 fusion This study
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the culture supernatant by wild-type EPEC E2348/69 but not
by ICC192, confirming that they are substrates of the LEE-
encoded type III secretion system (Fig. 2A). The recombinant
strains were then used to infect HeLa cell monolayers, and
TEM-1 translocation assays were performed as described by
Charpentier and Oswald (4). Wild-type and escN-EPEC
E2348/69 strains were subcultured in LB supplemented with
tetracycline and incubated for 16 h at 37°C. The cultures were
diluted 1/100 in DMEM supplemented with 10% fetal calf serum
and 2 mM glutamine at 37°C for 2.5 h (preactivation). HeLa cells
grown on glass coverslips were infected with 1 ml of preactivated
bacterial culture (multiplicity of infection,100:1) and incubated
at 37°C in 5% CO2. After 30 min of infection, isopropyl--D-
thiogalactopyranoside (IPTG) was added at a final concentration
of 1 mM, and the coverslips were incubated for an additional
hour. Cell monolayers were washed three times with phosphate-
buffered saline (PBS) and covered with 100 l of PBS plus 25 l
of 6XCCF2/AM solution freshly prepared from the CCF2/AM
Loading kit (CCF2/AM final concentration, 1 M; Invitrogen).
The cells were incubated in darkness at room temperature for
2 h of culture. Cells were washed three times with PBS and
observed under a Nikon Eclipse E600 fluorescence microscope
with a UV-2A filter set (330- to 380-nm excitation). Images,
captured using a Nikon DXM1200 digital camera, showed that
both NleC–TEM-1 and NleD–TEM-1 fusion proteins were
translocated into host cells by wild-type EPEC E2348/69
but not by ICC192, indicating that NleC and NleD constituted
novel translocated effectors of the LEE-encoded TTSS
(Fig. 2B).
In vitro analysis of nleC and nleD mutants of EPEC and
EHEC. Although the LEE of EPEC encodes all the proteins
required for A/E lesion formation, the prophage-carried effec-
tor TccP is additionally required for A/E lesion formation by
EHEC O157:H7 (3, 14). Therefore, to examine the contribu-
tion of NleC and NleD to A/E lesion formation and adherence
in vitro, we constructed nleC and nleD deletion mutants. Mu-
tations in nleC and nleD genes for EPEC E2349/69 and EHEC
85-170 were constructed by using the PCR one-step  red
recombination system (6). Each mutation was obtained using a
PCR substrate containing a kanamycin resistance gene flanked
by the 50 bases from the 5 and 3 ends of the target gene.
Plasmid pKD4 carrying the kanamycin resistance gene was
used as the PCR template. The PCR product was electropo-
rated into the recipient strains carrying the Red system expres-
sion plasmid pKD46, and mutants were selected on LB plates
with kanamycin. Recombinant clones were cured of pKD46
plasmid by growth at the nonpermissive temperature (42°C),
and mutation was confirmed by different PCRs using primers
TABLE 2. Primers used in this study
Name Primer sequence (5-3)
Z0990 FRT f....................................................ATGCGCCCTACGTCCCTCAACTTGGTATTACATCAGTCATCAAGGTCGAGTGTGTAGGCTGGAGCTGCTTCG
Z0990 FRT r ................................................... CTAAAGCAATGGATGCAGTCTTACCTGTTGGAATCCCAGACTCACTGTATCATATGAATATCCTCCTTAG
Z0986 FRT f.................................................... ATGAAAATTCCCTCATTACAGTCCAACTTCAACTTTTCCGCCCCGGCAGGTGTGTAGGCTGGAGCTGCTTCG
Z0986 FRT r ................................................... TCATTGCTGATTGTGTTTGTCCACATCCCCAAATGTAAAAATATAAGGCATATGAATATCCTCCTTAG
Z0990Ndel f ..................................................... GGTATTCCATATGCGCCCTACGTCCCTCA
Z0990Ecol r ..................................................... CGGAATTCTCAAGCAATGGATGCAGTC
Z0986Ndel f ..................................................... GGTATTCCATATGAAAATTCCCTCATTAC
Z0986EcoRI r .................................................. CGGAATTCGCTTGCTGATTGTGTTTGTC
FIG. 2. NleC and NleD are secreted and translocated into eukaryotic
cells in a LEE-encoded TTSS-dependent manner. (A) Wild-type EPEC
E2348/69 strain and a strain mutated in escN, ICC192, expressing NleC-
TEM or NleD-TEM fusions were grown in Dulbecco’s modified Eagle
medium; pellets and supernatants were probed by Western blot analysis
for the presence of TEM fusion proteins. (B) The same strains,
ICC192(pICC308) (a), EPEC E2348/69(pICC308) (b),
ICC192(pICC309) (c), and E2348/69 (pICC309) (d), were used to infect
HeLa cells; after infection, HeLa cells were washed and loaded with
CCF2/AM. The presence of TEM fusions in HeLa cells is revealed by a
blue fluorescence due to cleaving of CCF2/AM by the -lactamase en-
coded by TEM, whereas uncleaved CCF2/AM substrate fluoresces green.
VOL. 73, 2005 NOTES 8413
flanking the targeted region and primers into the kanamycin
resistance gene (not shown) and by Southern blotting (Fig. 1A)
with HindIII/BglII-digested genomic DNA purified with a
QBiogene GNOME DNA kit and a gene-specific PCR probe
labeled with the ECL Direct Nucleic Acid labeling kit (Amer-
sham Biosciences).
The ability of the nleC and nleD EPEC E2348/69 (ICC193
and ICC194, respectively) and EHEC 85-170 (ICC195 and
ICC196, respectively) strains to induce A/E lesion in vitro
(HEp-2 cells) and ex vivo (human intestinal in vitro organ
cultures [IVOC]) was examined. The fluorescent actin staining
test was performed on infected HEp-2 cells as described by
Knutton et al. (18). For IVOC, tissue was obtained (after
obtaining fully informed parental consent and local ethical
committee approval) with grasp forceps during routine endo-
scopic investigation of intestinal disorders with a Fujinon EG/
EC-41 pediatric endoscope. Proximal small intestinal mucosal
biopsies from the fourth part of the duodenum, which ap-
peared macroscopically normal, were taken for organ culture
experiments. Light microscopy subsequently showed no histo-
logical abnormality. IVOC infections were performed as de-
scribed previously (16). EPEC nleC (ICC193) and nleD
(ICC194) were examined using tissue samples from three pa-
tients (aged 29, 118, and 142 months). In each experiment, a
noninoculated sample (to exclude endogenous bacterial adhe-
sion) and a positive control (IVOC with parent strain E2348/69
to exclude host factors) were included. Samples were fixed with
2.5% glutaraldehyde, postfixed in 1% aqueous osmium tetrox-
ide, and processed for viewing with a JEOL JSM 5300 scanning
electron microscope (16).
No difference was seen in the ability of wild-type and nleC
and nleD mutant strains of either EPEC or EHEC to induce
actin polymerization on HEp-2 cells (data not shown). In ad-
dition, there was no difference in the pattern of adherence of
wild-type and mutant EPEC strains to HEp-2 cells, which all
exhibited localized adherence, or in the pattern of adherence
of wild-type EHEC and mutant strains, which all exhibited
diffuse adherence (data not shown). NleC and NleD are there-
fore not required for adherence to tissue culture cells or actin
accumulation in EPEC and EHEC. Similarly, all strains tested
were able to adhere to human intestinal tissue and induce A/E
lesions (Fig. 3), confirming that NleC and NleD do not play
a role in intimate attachment to human intestinal biopsy tissue
in vitro.
Colonization of lambs by nleC and nleD mutants of EHEC
O157:H7. As ruminants are considered an important reservoir
of EHEC, we therefore determined the contribution of NleC
and NleD to colonization of lambs and calves. Fifteen 6-week-
old cross-bred lambs were randomly divided into three equal
groups, supplied with food and water ad libitum, and con-
firmed to be free of EHEC O157 by enrichment and O157
immunomagnetic separation. All lambs were housed in bio-
secure containment level 2 accommodations. Each group was
housed in a separate room with its own air handling. Animals
were visited only by experienced staff who changed clothing
between each group. Five lambs were each dosed orally with
FIG. 3. NleC and NleD are not required for induction of A/E lesions. Scanning electron micrographs showing uninfected duodenal mucosa
(A) and duodenal mucosa infected for 8 h with parental EPEC E2348/69 strain (B), nleC mutant strain ICC193 (C), and nleD mutant strain ICC194
(D). Size bar, 1 m.
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109 CFU of either 85-170 Nalr, 85-170nleC::Kanr, or
85-170nleD::Kanr resuspended in 10 ml of PBS (pH 7.4).
Approximately 24 h after dosing and as required thereafter
for up to 27 days, rectal fecal samples from each lamb were
collected for direct plating onto sorbitol-MacConkey
(SMAC; Oxoid, Basingstoke, United Kingdom) plates sup-
plemented with either 15-g/ml nalidixic acid or 25-g/ml
kanamycin (Sigma). Samples which were negative by direct
plating were enriched in buffered peptone water for 6 h at 37°C
and then plated onto SMAC supplemented with the appropri-
ate antibiotic. Representative colonies were confirmed to be E.
coli O157 by latex agglutination (Oxoid, Basingstoke, United
Kingdom). The ability of the test strains to establish and persist
in lambs was investigated by monitoring viable bacteria recov-
ered in stools collected per rectum. In this model, wild-type
EHEC 85-170 produced a typical shedding pattern, persisting
in high numbers in the early stages of infection and then
declining until undetectable by day 10 postinfection (Fig. 4).
Wild-type EHEC 85-170 then remained undetectable by direct
plating or with enrichment for the remainder of the study (27
days in total; data not shown). In contrast, while ICC195 and
ICC196 showed levels of colonization that were similar those
of to wild-type EHEC 85-170 in the early stages of infection,
one animal continued to shed ICC196 (as detected by enrich-
ment) until 14 days postinfection (data not shown).
Coinfection of calves with EHEC O157:H7 wild-type and nleD
mutant. Recently, an EHEC O157:H7 strain EDL933 mutant
harboring a transposon insertion in nleD was identified by
signature-tagged mutagenesis as being attenuated following
inoculation of 10- to 14-day-old calves (9). Accordingly, we
tested the defined nleD mutant in coinfections. Conventional
Friesian bull calves aged 10 to 14 days were housed in high-
containment accommodations in tanks on tenderfoot mats and
fed on milk replacer twice daily with free access to water. Prior
to infection, calves were confirmed to be culture negative for
EHEC and Salmonella by direct plating of rectal swabs on
sorbitol-MacConkey agar containing 2.5-g/ml potassium tel-
lurite (T-SMAC) or Brilliant Green agar (Oxoid, Basingstoke,
United Kingdom), respectively. Presumptive EHEC were
screened for stx1 and stx2 genes as previously described (33)
and animals excreting stx-positive E. coli or Salmonella were
excluded. All calves were obtained from the same farm and
received colostrum from their respective dams for the first 24
to 48 h. Thereafter, no further colostrum was given. Total
serum-immunoglobulin levels were measured at 1 or 2 days of
age as a measure of colostrum intake by zinc sulfate turbidity
assay. Only calves with a zinc sulfate turbidity measurement of
10 were used.
Bacterial strains for inoculation were amplified in brain
heart infusion broth for 18 h at 37°C and adjusted to the
same optical density. Three calves were orally challenged
with ca. 1 	 1010 CFU of a 1:1 mixture of 85-170 Nalr and
the defined 85-170 Nalr nleD::Kanr mutant. Fecal samples
were collected once daily for 10 days by rectal palpation; calves
remained asymptomatic throughout. The amount of viable
EHEC per gram of feces was enumerated by plating triplicate
10-fold serial dilutions onto T-SMAC containing 2.5-g/ml
potassium tellurite and 20-g/ml nalidixic acid (T-SMAC–Nal)
and T-SMAC–Nal containing 50-g/ml kanamycin (T-SMAC–
Nal–Kan). The number of wild-type bacteria was calculated by
subtracting the viable count on T-SMAC–Nal–Kan from that
obtained using T-SMAC–Nal. Recovery of the mutant strain in
the feces was confirmed by PCR from selected colonies on
T-SMAC–Nal–Kan plates using the primers 5-ACAGAG
ACAAATGTCTTATATGA-3 and 5-CAGTCATAGCCG
AATAGCCT-3. The fecal shedding data were statistically an-
alyzed for the effect of mutation by means of an F-test, with the
data taken as repeated measurements (Proc Mixed; Statistical
Analysis System, SAS Institute, Cary, N.C.). P values of 
0.05
were taken to be significant. The log10-transformed fecal ex-
cretion data show that the magnitude and duration excretion of
the nleD mutant were very similar to those of the wild type; no
statistically significant reduction in shedding of the mutant
could be detected at any time postinoculation (Fig. 5).
The LEE-encoded TTSS of AEEC is essential for virulence
FIG. 4. The translocated effector proteins NleC and NleD are not
required for persistence of EHEC O157:H7 in lambs. Colonization
is indicated by viable bacterial counts from fecal samples taken at
different time points postinfection. Lambs were infected with ca.
109 CFU of the EHEC O157:H7 85-170 parental strain (closed circles),
nleC mutant (open squares), or nleD mutant (open circles). Error bars
show standard deviations.
FIG. 5. Course of fecal excretion of EHEC O157:H7 strains 85-170
Nalr and 85-170 Nalr nleD::Kanr, following coinfection of three ca.
14-day-old calves. Mean log10-transformed shedding data ( the stan-
dard error of the mean) for the wild-type (closed squares) and mutant
(open circles) strains is shown.
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and translocates at least 10 proteins from the bacterial cyto-
plasm into the host cell cytosol (13). Some of the translocated
effectors have been shown to be essential for colonization and
disease in various animal models of infection, including EspB
(8, 29) and EspD (8, 27), which together with EspA form the
EPEC/EHEC translocon required for the delivery of other
effector proteins into host cells (12). Tir (17, 22, 33), which is
essential for intimin binding and intimate attachment of the
bacteria to the host cell surface, and EspI/NleA are also es-
sential for virulence in several models of infection (15, 25);
however, other translocated effector proteins appear to make
little contribution to pathogenesis in animal infection models
(8, 25). Therefore, the contribution of various translocated
effectors to colonization and disease varies considerably.
Until recently, the only effector proteins known to be trans-
located by the LEE-encoded TTSS were also encoded within
the LEE (12). However, several novel effector proteins have
now been identified that are not encoded by LEE, yet they are
secreted and translocated into cells by the LEE-encoded TTSS
(13). Two of these putative non-LEE-encoded effectors, NleC
and NleD, were identified in C. rodentium by proteomic anal-
ysis of secreted proteins (8). The genes encoding NleC and
NleD are present in other AEEC strains, including EPEC and
EHEC, and are located in O-island 36 of the EHEC O157:H7
EDL933 genome. While NleC has no similarity with proteins
from non-AEEC strains, NleD shares some similarity with the
TTSS effector, HopPtoH, from the plant pathogen P. syringae
(31). Although the contribution of HopPtoH to the virulence
of P. syringae is unknown, both proteins share a common zinc
binding motif found in the neurotoxin of C. botulinum which
may be important for their function.
In this study, we demonstrated that NleC and NleD are true
translocated effectors of the LEE-encoded TTSS. An intact
LEE was required for the secretion of NleC–TEM-1 and
NleD–TEM-1 fusion proteins and for the translocation of the
fusion proteins into host cells. The observations that NleC and
NleD could enter cells suggested that these proteins may play
a direct role in host-pathogen interactions. To determine the
contribution of the proteins to virulence, we constructed nleC
and nleD deletion mutants in strains of EPEC and EHEC and
tested the mutants in several in vitro and animal models of
infection. The results showed that neither NleC nor NleD
played a role in A/E lesion formation, adherence to human
intestinal tissue, adherence to tissue culture cells, or carriage
and virulence in lambs or calves. Importantly, the calf model is
capable of detecting attenuation, as we have previously re-
ported that mutation of EHEC O157:H7 escN, tir, or z2200 and
EHEC O5/O111 efa1 causes a highly significant reduction in
fecal excretion of the respective mutants by 7 to 10 days post-
inoculation (9, 33, 34, 37).
As EDL933 nleD mutant was identified by signature-tagged
mutagenesis as being attenuated following inoculation of 10- to
14-day-old calves (9), we confirmed in separate coinfection
studies that the EDL933 Nalr nleD::miniTn5Km2 mutant
(11A3) was significantly attenuated relative to the parent strain
in three calves (P 
 0.01 at 6 days postinoculation; data not
shown). While this is consistent with the attenuation observed
in the initial signature-tagged mutagenesis screen (9), the data
with the defined 85-170 nleD::Kanr mutant in calves and lambs
imply that the attenuation of the EDL933 transposon mutant
may be the result of a second-site defect or strain-specific
effect. At this stage, the precise role of NleC and NleD in the
pathogenesis of infections with AEEC is unclear. Although in
this study we were unable to find a phenotype for NleC or
NleD, the fact that they are translocated into host cells sug-
gests that the proteins have the potential to influence host-
pathogen interactions. Our data suggest that as new putative
effector proteins emerge, the challenge will be to pinpoint their
role in infection, which may vary in different hosts and with
different bacterial isolates. This problem may be compounded
by the presence of one or several homologs in the one patho-
gen, as seen for EspF and EspG, which could offer more
functional redundancy among the translocated effectors.
We acknowledge Xavier Charpentier and Eric Oswald for technical
advice on the TEM-1 reporter system.
O.M. is supported by a Marie Curie Fellowship from the European
Commission. This work was supported by grants from the Wellcome
Trust and the BBSRC and Defra project OZ0707 (M.P.S.).
REFERENCES
1. Campellone, K. G., and J. M. Leong. 2003. Tails of two Tirs: actin pedestal
formation by enteropathogenic E. coli and enterohemorrhagic E. coli O157:
H7. Curr. Opin. Microbiol. 6:82–90.
2. Campellone, K. G., S. Rankin, T. Pawson, M. W. Kirschner, D. J. Tipper,
and J. M. Leong. 2004. Clustering of Nck by a 12-residue Tir phosphopeptide
is sufficient to trigger localized actin assembly. J. Cell Biol. 164:406–416.
3. Campellone, K. G., D. Robbins, and J. M. Leong. 2004. EspFU is a translo-
cated EHEC effector that interacts with Tir and N-WASP and promotes
Nck-independent actin assembly. Dev. Cell 7:217–228.
4. Charpentier, X., and E. Oswald. 2004. Analysis of type III translocation
signals of enteropathogenic and enterohemorrhagic Escherichia coli effectors
using TEM-1 -lactamase as a fluorescence-based reporter. J. Bacteriol.
186:5486–5495.
5. Dahan, S., S. Wiles, R. M. La Ragione, A. Best, M. J. Woodward, M. P.
Stevens, R. K. Shaw, Y. Chong, S. Knutton, A. Phillips, and G. Frankel.
2005. EspJ is a prophage-encoded type III effector protein of attaching and
effacing pathogens that modulates infection dynamics. Infect. Immun. 73:
679–686.
6. Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromo-
somal genes in Escherichia coli K12 using PCR products. Proc. Natl. Acad.
Sci. USA 97:6640–6645.
7. Deng, W., Y. Li, B. A. Vallance, and B. B. Finlay. 2001. Locus of enterocyte
effacement from Citrobacter rodentium: sequence analysis and evidence for
horizontal transfer among attaching and effacing pathogens. Infect. Immun.
69:6323–6335.
8. Deng, W., J. L. Puente, S. Gruenheid, Y. Li, B. A. Vallance, A. Vazquez, J.
Barba, J. A. Ibarra, P. O’Donnell, P. Metalnikov, K. Ashman, S. Lee, D.
Goode, T. Pawson, and B. B. Finlay. 2004. Dissecting virulence: systematic
and functional analyses of a pathogenicity island. Proc. Natl. Acad. Sci. USA
101:3597–3602.
9. Dziva, F., P. M. van Diemen, M. P. Stevens, A. J. Smith, and T. S. Wallis.
2004. Identification of Escherichia coli O157:H7 genes influencing coloniza-
tion of the bovine gastrointestinal tract using signature-tagged mutagenesis.
Microbiology 150:3631–3645.
10. Elliott, S. J., E. O. Krejany, J. L. Mellies, R. M. Robins-Browne, C.
Sasakawa, and J. B. Kaper. 2001. EspG, a novel type III system-secreted
protein from enteropathogenic Escherichia coli with similarities to VirA of
Shigella flexneri. Infect. Immun. 69:4027–4033.
11. Elliott, S. J., L. A. Wainwright, T. K. McDaniel, K. G. Jarvis, Y. K. Deng,
L. C. Lai, B. P. McNamara, M. S. Donnenberg, and J. B. Kaper. 1998. The
complete sequence of the locus of enterocyte effacement (LEE) from en-
teropathogenic Escherichia coli E2348/69. Mol. Microbiol. 28:1–4.
12. Frankel, G., A. D. Phillips, I. Rosenshine, G. Dougan, J. B. Kaper, and S.
Knutton. 1998. Enteropathogenic and enterohaemorrhagic Escherichia coli:
more subversive elements. Mol. Microbiol. 30:911–921.
13. Garmendia, J., G. Frankel, and V. F. Crepin. 2005. Enteropathogenic and
enterohemorrhagic Escherichia coli infections: translocation, translocation,
translocation. Infect. Immun. 73:2573–2585.
14. Garmendia, J., A. Phillips, Y. Chong, S. Schuller, O. Marches, S. Dahan, E.
Oswald, R. K. Shaw, S. Knutton, and G. Frankel. 2004. TccP is an entero-
haemorrhagic E. coli O157:H7 type III effector protein that couples Tir to
the actin-cytoskeleton. Cell. Microbiol. 6:1167–1183.
15. Gruenheid, S., I. Sekirov, N. A. Thomas, W. Deng, P. O’Donnell, D. Goode,
Y. Li, E. A. Frey, N. F. Brown, P. Metalnikov, T. Pawson, K. Ashman,
and B. B. Finlay. 2004. Identification and characterization of NleA, a non-
8416 NOTES INFECT. IMMUN.
LEE encoded type III translocated virulence factor of enterohaemorrhagic
Escherichia coli O157:H7. Mol. Microbiol. 51:1233–1249.
16. Hicks, S., G. Frankel, J. B. Kaper, G. Dougan, and A. D. Phillips. 1998. Role
of intimin and bundle-forming pili in enteropathgenic Escherichia coli adhe-
sion to pediatric intestinal tissue in vitro. Infect. Immun. 66:1570–1578.
17. Kenny, B., R. DeVinney, M. Stein, D. J. Reinscheid, E. A. Frey, and B. B.
Finlay. 1997. Enteropathogenic E. coli (EPEC) transfers its receptor for
intimate adherence into mammalian cells. Cell 91:511–520.
18. Knutton, S., T. Baldwin, P. H. Williams, and A. S. McNeish. 1989. Actin
accumulation at sites of bacterial adhesion to tissue culture cells: basis of a
new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia
coli. Infect. Immun. 57:1290–1298.
19. Knutton, S., D. R. Lloyd, and A. S. McNeish. 1987. Adhesion of entero-
pathogenic Escherichia coli to human intestinal enterocytes and cultured
human intestinal mucosa. Infect. Immun. 55:69–77.
20. Levine, M. M., E. J. Berquist, D. R. Nalin, D. H. Waterman, R. B. Hornick,
C. R. Young, S. Stoman, and B. Rowe. 1978. Escherichia coli that cause
diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are
non-invasive. Lancet i:119–122.
21. Marches, O., T. N. Ledger, M. Boury, M. Ohara, X. Tu, F. Goffaux, J. Mainil,
I. Rosenshine, M. Sugai, J. De Rycke, and E. Oswald. 2003. Enteropatho-
genic and enterohaemorrhagic Escherichia coli deliver a novel effector called
Cif, which blocks cell cycle G2/M transition. Mol. Microbiol. 50:1553–1567.
22. Marches, O., J. P. Nougayrede, S. Boullier, L. J. Maini, G. Charlier, I.
Raymond, P. Pohl, M. Boury, J. De Rycke, A. Milon, and E. Oswald. 2000.
Role of Tir and intimin in the virulence of rabbit enteropathogenic
Escherichia coli serotype O103:H2. Infect. Immun. 68:2171–2182.
23. Matsuzawa, T., A. Kuwae, S. Yoshida, C. Sasakawa, and A. Abe. 2004.
Enteropathogenic Escherichia coli activates the RhoA signaling pathway via
the stimulation of GEF-H1. EMBO J. 23:3570–3582.
24. McDaniel, T. K., K. G. Jarvis, M. S. Donnenberg, and J. B. Kaper. 1995. A
genetic locus of enterocyte effacement conserved among diverse enterobac-
terial pathogens. Proc. Natl. Acad. Sci. USA 92:1664–1668.
25. Mundy, M., L. Petrovska, K. Smollett, N. Simpson, R. K. Wilson, J. Yu, X.
Tu, I. Rosenshine, S. Clare, G. Dougan, and G. Frankel. 2004. Identification
of a novel Citrobacter rodentium type III secreted protein, EspI, and the roles
of this and other secreted proteins in infection. Infect. Immun. 72:2288–2302.
26. Mundy, R., C. Jenkins, J. Yu, H. Smith, and G. Frankel. 2004. Distribu-
tion of espI among clinical enterohaemorrhagic and enteropathogenic
Escherichia coli isolates. J. Med. Microbiol. 53:1145–1149.
27. Mundy, R., D. Pickard, R. K. Wilson, C. P. Simmons, G. Dougan, and G.
Frankel. 2003. Identification of a novel type IV pilus gene cluster required
for gastrointestinal colonization of Citrobacter rodentium. Mol. Microbiol.
48:795–809.
28. Nataro, J. P., and J. B. Kaper. 1998. Diarrheagenic Escherichia coli. Clin.
Microbiol. Rev. 11:142–201.
29. Newman, J. V., B. A. Zabel, S. S. Jha, and D. B. Schauer. 1999. Citrobacter
rodentium espB is necessary for signal transduction and for infection of
laboratory mice. Infect. Immun. 67:6019–6025.
30. Perna, N. T., G. F. Mayhew, G. Posfai, S. Elliott, M. S. Donnenberg, J. B.
Kaper, and F. R. Blattner. 1998. Molecular evolution of a pathogenicity
island from enterohemorrhagic Escherichia coli O157:H7. Infect. Immun.
66:3810–3817.
31. Petnicki-Ocwieja, T., D. J. Schneider, V. C. Tam, S. T. Chancey, L. Shan, Y.
Jamir, L. M. Schechter, M. D. Janes, C. R. Buell, X. Tang, A. Collmer, and
J. R. Alfano. 2002. Genomewide identification of proteins secreted by the
Hrp type III protein secretion system of Pseudomonas syringae pv. tomato
DC3000. Proc. Natl. Acad. Sci. USA 99:7652–7657.
32. Shaw, R. K., K. Smollett, J. Cleary, J. Garmendia, A. Straatman-Iwanowska,
G. Frankel, and S. Knutton. 2005. Enteropathogenic Escherichia coli type III
effectors EspG and EspG2 disrupt the microtubule network of intestinal
epithelial cells. Infect. Immun. 73:4385–4390.
33. Stevens, M. P., A. J. Roe, I. Vlisidou, P. M. van Diemen, R. M. La Ragione,
A. Best, M. J. Woodward, D. L. Gally, and T. S. Wallis. 2004. Mutation of
toxB and a truncated version of the efa-1 gene in Escherichia coli O157:H7
influences the expression and secretion of locus of enterocyte effacement-
encoded proteins but not intestinal colonization in calves or sheep. Infect.
Immun. 72:5402–5411.
34. Stevens, M. P., P. M. van Diemen, G. Frankel, A. D. Phillips, and T. S.
Wallis. 2002. Efa1 influences colonization of the bovine intestine by Shiga
toxin-producing Escherichia coli serotypes O5 and O111. Infect. Immun.
70:5158–5166.
35. Tauschek, M., R. A. Strugnell, and R. M. Robins-Browne. 2002. Character-
ization and evidence of mobilization of the LEE pathogenicity island of
rabbit-specific strains of enteropathogenic Escherichia coli. Mol. Microbiol.
44:1533–1550.
36. Tzipori, S., H. Karch, K. I. Wachsmuth, R. M. Robins-Browne, A. D.
O’Brien, H. Lior, M. L. Cohen, J. Smithers, and M. M. Levine. 1987. Role
of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of
infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnoto-
biotic piglets. Infect. Immun. 55:3117–3125.
37. van Diemen, P. M., F. Dziva, M. P. Stevens, and T. S. Wallis. 2005. Identi-
fication of enterohemorrhagic Escherichia coli O26:H genes required for
intestinal colonization in calves. Infect. Immun. 73:1735–1743.
38. Viswanathan, V. K., A. Koutsouris, S. Lukic, M. Pilkinton, I. Simonovic, M.
Simonovic and, G. Hecht. 2004. Comparative analysis of EspF from entero-
pathogenic and enterohemorrhagic Escherichia coli in alteration of epithelial
barrier function. Infect. Immun. 72:3218–3227.
Editor: D. L. Burns
VOL. 73, 2005 NOTES 8417
